Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
110.21
+1.15 (1.05%)
Jul 16, 2025, 10:46 AM - Market open
Gilead Sciences Stock Forecast
Stock Price Forecast
The 24 analysts that cover Gilead Sciences stock have a consensus rating of "Buy" and an average price target of $110.95, which forecasts a 0.67% increase in the stock price over the next year. The lowest target is $80 and the highest is $140.
Price Target: $110.95 (+0.67%)
Analyst Consensus: Buy
* Price targets were last updated on May 5, 2025.
Analyst Ratings
The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 12 | 12 | 13 | 13 | 13 | 12 |
| Hold | 11 | 11 | 9 | 9 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 27 | 26 | 25 | 25 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 21, 2025 |
| Mizuho | Mizuho | Buy Maintains $100 → $117 | Buy | Maintains | $100 → $117 | +6.16% | May 5, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $132 → $125 | Buy | Maintains | $132 → $125 | +13.42% | Apr 25, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $130 → $135 | Buy | Maintains | $130 → $135 | +22.49% | Apr 25, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 25, 2025 |
Financial Forecast
Revenue This Year
29.24B
from 28.75B
Increased by 1.69%
Revenue Next Year
30.31B
from 29.24B
Increased by 3.67%
EPS This Year
8.12
from 0.38
Increased by 2,037.06%
EPS Next Year
8.67
from 8.12
Increased by 6.71%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 30.9B | 32.5B | 33.5B | ||
| Avg | 29.2B | 30.3B | 31.8B | ||
| Low | 27.7B | 28.2B | 29.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.5% | 11.1% | 10.5% | ||
| Avg | 1.7% | 3.7% | 5.0% | ||
| Low | -3.6% | -3.7% | -3.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.63 | 9.87 | 10.69 | ||
| Avg | 8.12 | 8.67 | 9.29 | ||
| Low | 7.56 | 6.32 | 6.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2,171.3% | 21.5% | 23.3% | ||
| Avg | 2,037.1% | 6.7% | 7.2% | ||
| Low | 1,888.4% | -22.2% | -21.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.